Biochemistry, Genetics and Molecular Biology
DNA Repair
100%
Cell Cycle
52%
Gene Expression Profiling
45%
Gene Expression
45%
DNA Damage Response
42%
Pediatrics
41%
Alternative Splicing
41%
RNA Interference
41%
DNA
38%
Mutation
37%
Nested Gene
36%
Relapse
30%
Phenotype
27%
Protein
24%
Nucleosome
23%
Kinase
20%
Messenger RNA
20%
Isoform
20%
Enzyme Activity
20%
RAD51
20%
Interactome
20%
DNA Glycosylase
20%
Long Noncoding RNA
20%
Glycosyltransferase
20%
Chromatin
20%
Isocitrate Dehydrogenase
20%
Genome Instability
20%
Cell Migration
20%
Dynamics
20%
P53
20%
Centromere
20%
CpG Island
20%
Intron
20%
Sensibility
20%
pH
20%
Epigenetics
20%
RNA
17%
Gene Signature
17%
Radiation
16%
Homologous Recombination
15%
Regulatory Mechanism
13%
Telomere
13%
Candidate Gene
12%
Sample
12%
DNA Damage
11%
Association
10%
RNA Sequencing
10%
Non-Homologous End Joining
10%
Drug Response
10%
RAD52
10%
Genetics
9%
Progression Free Survival
8%
Classification
8%
Comprehension
8%
Drive
8%
Telomere Homeostasis
7%
Development
7%
Survival
7%
Genotyping
6%
down Regulation
6%
Genetic Screen
6%
CRISPR/Cas9
6%
Gene Function
6%
CENPA
6%
Drug Resistance
5%
RNA Splicing
5%
Gene Network
5%
Nuclease
5%
Chemosensitivity
5%
Transcription Factor
5%
Coding
5%
Data Base
5%
Time
5%
Drug Sensitivity
5%
Transcriptome
5%
Medicine and Dentistry
Ganglioglioma
83%
DNA Repair
52%
Cell Cycle
41%
Pediatrics
41%
Gene Expression
38%
Analysis
33%
Gene
33%
Combination Therapy
31%
Therapeutic Procedure
26%
Phenotype
22%
Patient
21%
Smoking
20%
Molecular Evolution
20%
Glioblastoma
20%
Alternative RNA Splicing
20%
Genomic Instability
20%
CpG Island
20%
Mocetinostat
20%
Isocitrate Dehydrogenase
20%
Lung
20%
Chromatin
20%
Neoplasm
19%
Malignant Neoplasm
17%
Radiation Therapy
15%
DNA Damage Response
14%
Biopsy
13%
Carcinogenesis
13%
Relapse
12%
Specimen
12%
Protein
11%
Temozolomide
10%
Epigenomics
9%
Development
7%
Chemotherapy
7%
DNA
7%
Recurrent Disease
7%
Primary Tumor
7%
Non Small Cell Lung Cancer
6%
Comprehension
6%
Surgery
5%
Tumor Recurrence
5%
Chaperone
5%
Survival
5%
Alkylating Antineoplastic Agent
5%
Progression Free Survival
5%